-
1
-
-
24944563849
-
ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines
-
American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) doi:10.1016/j.jacc.2005.08.022
-
Hunt SA, American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) (2005) ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 46: e1-e82. doi:10.1016/j.jacc.2005.08.022.
-
(2005)
J Am Coll Cardiol
, vol.46
-
-
Hunt, S.A.1
-
2
-
-
77954709873
-
Selection of cardiac transplantation candidates in 2010
-
doi:10.1161/CIRCULATIONAHA.109.858076
-
Mancini D, Lietz K (2010) Selection of cardiac transplantation candidates in 2010. Circulation 122: 173-183. doi:10.1161/CIRCULATIONAHA.109.858076.
-
(2010)
Circulation
, vol.122
, pp. 173-183
-
-
Mancini, D.1
Lietz, K.2
-
3
-
-
84855353573
-
Heart disease and stroke statistics - 2012 Update: A report from the American Heart Association
-
doi:10.1161/CIR.0b013e31823ac046
-
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, et al. (2012) Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 125: e2-e220. doi:10.1161/CIR.0b013e31823ac046.
-
(2012)
Circulation
, vol.125
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
Benjamin, E.J.4
Berry, J.D.5
-
4
-
-
84873705765
-
Stem cell therapy: Promising treatment in heart failure?
-
doi:10.1007/s11897-012-0128-2
-
Loughran JH, Chugh AR, Ismail I, Bolli R (2013) Stem cell therapy: promising treatment in heart failure? Curr Heart Fail Rep 10: 73-80. doi:10.1007/s11897-012-0128-2.
-
(2013)
Curr Heart Fail Rep
, vol.10
, pp. 73-80
-
-
Loughran, J.H.1
Chugh, A.R.2
Ismail, I.3
Bolli, R.4
-
5
-
-
79952299939
-
Rescuing the failing heart by targeted gene transfer
-
doi:10.1016/j.jacc.2010.11.023
-
Kawase Y, Ladage D, Hajjar RJ (2011) Rescuing the failing heart by targeted gene transfer. J Am Coll Cardiol 57: 1169-1180. doi:10.1016/j.jacc. 2010.11.023.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1169-1180
-
-
Kawase, Y.1
Ladage, D.2
Hajjar, R.J.3
-
6
-
-
84859778293
-
mTOR signaling in growth control and disease
-
doi:10.1016/j.cell.2012.03.017
-
Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149: 274-293. doi:10.1016/j.cell.2012.03.017.
-
(2012)
Cell
, vol.149
, pp. 274-293
-
-
Laplante, M.1
Sabatini, D.M.2
-
7
-
-
84871518109
-
Molecular basis of physiological heart growth: Fundamental concepts and new players
-
doi:10.1038/nrm3495
-
Maillet M, van Berlo JH, Molkentin JD (2013) Molecular basis of physiological heart growth: fundamental concepts and new players. Nat Rev Mol Cell Biol 14: 38-48. doi:10.1038/nrm3495.
-
(2013)
Nat Rev Mol Cell Biol
, vol.14
, pp. 38-48
-
-
Maillet, M.1
Van Berlo, J.H.2
Molkentin, J.D.3
-
8
-
-
23644439061
-
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
-
doi:10.1172/JCI24682
-
Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, et al. (2005) Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 115: 2108-2118. doi:10.1172/JCI24682.
-
(2005)
J Clin Invest
, vol.115
, pp. 2108-2118
-
-
Shiojima, I.1
Sato, K.2
Izumiya, Y.3
Schiekofer, S.4
Ito, M.5
-
9
-
-
79953316595
-
Lysosomal positioning coordinates cellular nutrient responses
-
doi:10.1038/ncb2204
-
Korolchuk VI, Saiki S, Lichtenberg M, Siddiqi FH, Roberts EA, et al. (2011) Lysosomal positioning coordinates cellular nutrient responses. Nat Cell Biol 13: 453-460. doi:10.1038/ncb2204.
-
(2011)
Nat Cell Biol
, vol.13
, pp. 453-460
-
-
Korolchuk, V.I.1
Saiki, S.2
Lichtenberg, M.3
Siddiqi, F.H.4
Roberts, E.A.5
-
10
-
-
33646023695
-
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
-
doi:10.1016/j.molcel.2006.03.029
-
Sarbassov DD, Ali SM, Sengupta S, Sheen J-H, Hsu PP, et al. (2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol Cell 22: 159-168. doi:10.1016/j.molcel.2006.03.029.
-
(2006)
Mol Cell
, vol.22
, pp. 159-168
-
-
Sarbassov, D.D.1
Ali, S.M.2
Sengupta, S.3
Sheen, J.-H.4
Hsu, P.P.5
-
11
-
-
84865582428
-
Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency
-
doi:10.1111/j.1600-6143.2012.04131.x
-
Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, et al. (2012) Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant 12: 2487-2497. doi:10.1111/j.1600-6143.2012.04131.x.
-
(2012)
Am J Transplant
, vol.12
, pp. 2487-2497
-
-
Zuckermann, A.1
Keogh, A.2
Crespo-Leiro, M.G.3
Mancini, D.4
Vilchez, F.G.5
-
12
-
-
4544310044
-
The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo
-
doi:10.1023/B:CARD.0000041245. 61136.56
-
Boluyt MO, Li ZB, Loyd AM, Scalia AF, Cirrincione GM, et al. (2004) The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc Drugs Ther 18: 257-267. doi:10.1023/B:CARD.0000041245. 61136.56.
-
(2004)
Cardiovasc Drugs Ther
, vol.18
, pp. 257-267
-
-
Boluyt, M.O.1
Li, Z.B.2
Loyd, A.M.3
Scalia, A.F.4
Cirrincione, G.M.5
-
13
-
-
0028847159
-
Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy
-
Sadoshima J, Izumo S (1995) Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy. Circ Res 77: 1040-1052.
-
(1995)
Circ Res
, vol.77
, pp. 1040-1052
-
-
Sadoshima, J.1
Izumo, S.2
-
14
-
-
0032190906
-
Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes
-
Simm A, Schlüter K, Diez C, Piper HM, Hoppe J (1998) Activation of p70(S6) kinase by beta-adrenoceptor agonists on adult cardiomyocytes. J Mol Cell Cardiol 30: 2059-2067.
-
(1998)
J Mol Cell Cardiol
, vol.30
, pp. 2059-2067
-
-
Simm, A.1
Schlüter, K.2
Diez, C.3
Piper, H.M.4
Hoppe, J.5
-
15
-
-
71649084135
-
Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction
-
doi:10.1016/j.jacc.2009.08.031
-
Buss SJ, Muenz S, Riffel JH, Malekar P, Hagenmueller M, et al. (2009) Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 54: 2435-2446. doi:10.1016/j.jacc.2009.08.031.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2435-2446
-
-
Buss, S.J.1
Muenz, S.2
Riffel, J.H.3
Malekar, P.4
Hagenmueller, M.5
-
16
-
-
33746699629
-
Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis
-
doi:10.1097/01.hjh.0000239304.01496.83
-
Gao X-M, Wong G, Wang B, Kiriazis H, Moore X-L, et al. (2006) Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 24: 1663-1670. doi:10.1097/01.hjh.0000239304.01496.83.
-
(2006)
J Hypertens
, vol.24
, pp. 1663-1670
-
-
Gao, X.-M.1
Wong, G.2
Wang, B.3
Kiriazis, H.4
Moore, X.-L.5
-
17
-
-
34347244963
-
Rapamycin prevents thyroid hormone-induced cardiac hypertrophy
-
doi:10.1210/en.2007-0099
-
Kuzman JA, O'Connell TD, Gerdes AM (2007) Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 148: 3477-3484. doi:10.1210/en.2007-0099.
-
(2007)
Endocrinology
, vol.148
, pp. 3477-3484
-
-
Kuzman, J.A.1
O'Connell, T.D.2
Gerdes, A.M.3
-
18
-
-
3042608187
-
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
-
doi:10.1161/01.CIR.0000130641.08705.45
-
McMullen JR, Sherwood MC, Tarnavski O, Zhang L, Dorfman AL, et al. (2004) Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 109: 3050-3055. doi:10.1161/01.CIR.0000130641.08705.45.
-
(2004)
Circulation
, vol.109
, pp. 3050-3055
-
-
McMullen, J.R.1
Sherwood, M.C.2
Tarnavski, O.3
Zhang, L.4
Dorfman, A.L.5
-
19
-
-
73349120282
-
Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats
-
doi:10.1161/HYPERTENSIONAHA.109.138818
-
Soesanto W, Lin H-Y, Hu E, Lefler S, Litwin SE, et al. (2009) Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats. Hypertension 54: 1321-1327. doi:10.1161/HYPERTENSIONAHA.109.138818.
-
(2009)
Hypertension
, vol.54
, pp. 1321-1327
-
-
Soesanto, W.1
Lin, H.-Y.2
Hu, E.3
Lefler, S.4
Litwin, S.E.5
-
20
-
-
34548185475
-
Acute and chronic ventricular-arterial coupling in systole and diastole: Insights from an elderly hypertensive model
-
doi:10.1161/HYPERTENSIONAHA.107.090092
-
Shapiro BP, Lam CSP, Patel JB, Mohammed SF, Krüger M, et al. (2007) Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension 50: 503-511. doi:10.1161/HYPERTENSIONAHA.107.090092.
-
(2007)
Hypertension
, vol.50
, pp. 503-511
-
-
Shapiro, B.P.1
Lam, C.S.P.2
Patel, J.B.3
Mohammed, S.F.4
Krüger, M.5
-
21
-
-
0037382861
-
Rapamycin attenuates load-induced cardiac hypertrophy in mice
-
doi:10.1161/01.CIR.0000057979.36322.88
-
Shioi T, McMullen JR, Tarnavski O, Converso K, Sherwood MC, et al. (2003) Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107: 1664-1670. doi:10.1161/01.CIR.0000057979.36322.88.
-
(2003)
Circulation
, vol.107
, pp. 1664-1670
-
-
Shioi, T.1
McMullen, J.R.2
Tarnavski, O.3
Converso, K.4
Sherwood, M.C.5
-
22
-
-
41449085132
-
A method to measure cardiac autophagic flux in vivo
-
Iwai-Kanai E, Yuan H, Huang C, Sayen MR, Perry-Garza CN, et al. (2008) A method to measure cardiac autophagic flux in vivo. Autophagy 4: 322-329.
-
(2008)
Autophagy
, vol.4
, pp. 322-329
-
-
Iwai-Kanai, E.1
Yuan, H.2
Huang, C.3
Sayen, M.R.4
Perry-Garza, C.N.5
-
23
-
-
75749122303
-
Methods in mammalian autophagy research
-
doi:10.1016/j.cell.2010.01.028
-
Mizushima N, Yoshimori T, Levine B (2010) Methods in mammalian autophagy research. Cell 140: 313-326. doi:10.1016/j.cell.2010.01.028.
-
(2010)
Cell
, vol.140
, pp. 313-326
-
-
Mizushima, N.1
Yoshimori, T.2
Levine, B.3
-
24
-
-
0041357130
-
Minimally invasive aortic banding in mice: Effects of altered cardiomyocyte insulin signaling during pressure overload
-
doi:10.1152/ajpheart.00108.2003
-
Hu P, Zhang D, Swenson L, Chakrabarti G, Abel ED, et al. (2003) Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285: H1261-H1269. doi:10.1152/ajpheart.00108.2003.
-
(2003)
Am J Physiol Heart Circ Physiol
, vol.285
-
-
Hu, P.1
Zhang, D.2
Swenson, L.3
Chakrabarti, G.4
Abel, E.D.5
-
25
-
-
77955172275
-
Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects"
-
doi:10.1161/CIRCULATIONAHA.109.915215
-
Mohammed SF, Ohtani T, Korinek J, Lam CSP, Larsen K, et al. (2010) Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects". Circulation 122: 370-378. doi:10.1161/CIRCULATIONAHA.109.915215.
-
(2010)
Circulation
, vol.122
, pp. 370-378
-
-
Mohammed, S.F.1
Ohtani, T.2
Korinek, J.3
Lam, C.S.P.4
Larsen, K.5
-
26
-
-
84861095145
-
Variable phenotype in murine transverse aortic constriction
-
doi:10.1016/j.carpath.2011.05.002
-
Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, et al. (2011) Variable phenotype in murine transverse aortic constriction. Cardiovasc Pathol. doi:10.1016/j.carpath.2011.05.002.
-
(2011)
Cardiovasc Pathol
-
-
Mohammed, S.F.1
Storlie, J.R.2
Oehler, E.A.3
Bowen, L.A.4
Korinek, J.5
-
27
-
-
0036873457
-
Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan
-
Holtwick R, Baba HA, Ehler E, Risse D, Vobeta M, et al. (2002) Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan. J Cardiovasc Pharmacol 40: 725-734.
-
(2002)
J Cardiovasc Pharmacol
, vol.40
, pp. 725-734
-
-
Holtwick, R.1
Baba, H.A.2
Ehler, E.3
Risse, D.4
Vobeta, M.5
-
28
-
-
64249100372
-
Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction
-
doi:10.1161/CIRCULATIONAHA.108.823799
-
Doser TA, Turdi S, Thomas DP, Epstein PN, Li S-Y, et al. (2009) Transgenic overexpression of aldehyde dehydrogenase-2 rescues chronic alcohol intake-induced myocardial hypertrophy and contractile dysfunction. Circulation 119: 1941-1949. doi:10.1161/CIRCULATIONAHA.108.823799.
-
(2009)
Circulation
, vol.119
, pp. 1941-1949
-
-
Doser, T.A.1
Turdi, S.2
Thomas, D.P.3
Epstein, P.N.4
Li, S.-Y.5
-
29
-
-
78751507979
-
Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart
-
doi:10.1093/cvr/cvq308
-
Creemers EE, Pinto YM (2011) Molecular mechanisms that control interstitial fibrosis in the pressure-overloaded heart. Cardiovasc Res 89: 265-272. doi:10.1093/cvr/cvq308.
-
(2011)
Cardiovasc Res
, vol.89
, pp. 265-272
-
-
Creemers, E.E.1
Pinto, Y.M.2
-
30
-
-
34648843625
-
Mechanisms of cardiac fibrosis in hypertension
-
Greenwich
-
Díez J (2007) Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 9: 546-550.
-
(2007)
J Clin Hypertens
, vol.9
, pp. 546-550
-
-
Díez, J.1
-
31
-
-
73449112950
-
Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation
-
doi:10.1161/CIRCULATIONAHA.108.812685
-
Villari B, Sossalla S, Ciampi Q, Petruzziello B, Turina J, et al. (2009) Persistent diastolic dysfunction late after valve replacement in severe aortic regurgitation. Circulation 120: 2386-2392. doi:10.1161/CIRCULATIONAHA.108. 812685.
-
(2009)
Circulation
, vol.120
, pp. 2386-2392
-
-
Villari, B.1
Sossalla, S.2
Ciampi, Q.3
Petruzziello, B.4
Turina, J.5
-
32
-
-
33847124544
-
Decompensation of cardiac hypertrophy: Cellular mechanisms and novel therapeutic targets
-
doi:10.1152/physiol.00033.2006
-
Diwan A, Dorn GW (2007) Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets. Physiology 22: 56-64. doi:10.1152/physiol.00033.2006.
-
(2007)
Physiology
, vol.22
, pp. 56-64
-
-
Diwan, A.1
Dorn, G.W.2
-
33
-
-
79953033875
-
Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice
-
doi:10.1161/CIRCULATIONAHA.110.977066
-
Shende P, Plaisance I, Morandi C, Pellieux C, Berthonneche C, et al. (2011) Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123: 1073-1082. doi:10.1161/CIRCULATIONAHA.110.977066.
-
(2011)
Circulation
, vol.123
, pp. 1073-1082
-
-
Shende, P.1
Plaisance, I.2
Morandi, C.3
Pellieux, C.4
Berthonneche, C.5
-
34
-
-
58149349850
-
Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft
-
doi:10.1097/TP.0b013e318189049a
-
Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, et al. (2008) Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation 86: 1395-1400. doi:10.1097/TP.0b013e318189049a.
-
(2008)
Transplantation
, vol.86
, pp. 1395-1400
-
-
Raichlin, E.1
Chandrasekaran, K.2
Kremers, W.K.3
Frantz, R.P.4
Clavell, A.L.5
-
35
-
-
67650944993
-
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
-
doi:10.1038/nature08221
-
Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395. doi:10.1038/nature08221.
-
(2009)
Nature
, vol.460
, pp. 392-395
-
-
Harrison, D.E.1
Strong, R.2
Sharp, Z.D.3
Nelson, J.F.4
Astle, C.M.5
-
36
-
-
21244458013
-
Structure of S6 kinase 1 determines whether raptorm-TOR or rictor-mTOR phosphorylates its hydrophobic motif site
-
doi:10.1074/jbc.C500125200
-
Ali SM, Sabatini DM (2005) Structure of S6 kinase 1 determines whether raptorm-TOR or rictor-mTOR phosphorylates its hydrophobic motif site. J Biol Chem 280: 19445-19448. doi:10.1074/jbc.C500125200.
-
(2005)
J Biol Chem
, vol.280
, pp. 19445-19448
-
-
Ali, S.M.1
Sabatini, D.M.2
-
37
-
-
70350418625
-
mTOR signaling at a glance
-
doi:10.1242/jcs.051011
-
Laplante M, Sabatini DM (2009) mTOR signaling at a glance. J Cell Sci 122: 3589-3594. doi:10.1242/jcs.051011.
-
(2009)
J Cell Sci
, vol.122
, pp. 3589-3594
-
-
Laplante, M.1
Sabatini, D.M.2
-
38
-
-
84874523611
-
Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway
-
doi:10.1016/j.ajpath.2012.11.009
-
Kanamori H, Takemura G, Goto K, Tsujimoto A, Ogino A, et al. (2013) Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am J Pathol 182: 701-713. doi:10.1016/j.ajpath.2012.11.009.
-
(2013)
Am J Pathol
, vol.182
, pp. 701-713
-
-
Kanamori, H.1
Takemura, G.2
Goto, K.3
Tsujimoto, A.4
Ogino, A.5
-
39
-
-
84866312155
-
Pharmacological modulation of autophagy during cardiac stress
-
doi:10.1097/FJC.0b013e3182575f61
-
Sciarretta S, Zhai P, Volpe M, Sadoshima J (2012) Pharmacological modulation of autophagy during cardiac stress. J Cardiovasc Pharmacol 60: 235-241. doi:10.1097/FJC.0b013e3182575f61.
-
(2012)
J Cardiovasc Pharmacol
, vol.60
, pp. 235-241
-
-
Sciarretta, S.1
Zhai, P.2
Volpe, M.3
Sadoshima, J.4
-
40
-
-
34249714158
-
The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress
-
doi:10.1038/nm1574
-
Nakai A, Yamaguchi O, Takeda T, Higuchi Y, Hikoso S, et al. (2007) The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 13: 619-624. doi:10.1038/nm1574.
-
(2007)
Nat Med
, vol.13
, pp. 619-624
-
-
Nakai, A.1
Yamaguchi, O.2
Takeda, T.3
Higuchi, Y.4
Hikoso, S.5
-
41
-
-
77955290360
-
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
-
doi:10.1172/JCI43008
-
Zhang D, Contu R, Latronico MVG, Zhang J, Zhang JL, et al. (2010) MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 120: 2805-2816. doi:10.1172/JCI43008.
-
(2010)
J Clin Invest
, vol.120
, pp. 2805-2816
-
-
Zhang, D.1
Contu, R.2
Latronico, M.V.G.3
Zhang, J.4
Zhang, J.L.5
-
42
-
-
79955751138
-
Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium
-
doi:10.1152/ajpheart.00545.2010
-
Harston RK, McKillop JC, Moschella PC, Van Laer A, Quinones LS, et al. (2011) Rapamycin treatment augments both protein ubiquitination and Akt activation in pressure-overloaded rat myocardium. Am J Physiol Heart Circ Physiol 300: H1696-H1706. doi:10.1152/ajpheart.00545.2010.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
-
-
Harston, R.K.1
McKillop, J.C.2
Moschella, P.C.3
Van Laer, A.4
Quinones, L.S.5
-
43
-
-
80052581224
-
Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish
-
doi:10.1161/CIRCRESAHA.111.248260
-
Ding Y, Sun X, Huang W, Hoage T, Redfield M, et al. (2011) Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res 109: 658-669. doi:10.1161/CIRCRESAHA.111.248260.
-
(2011)
Circ Res
, vol.109
, pp. 658-669
-
-
Ding, Y.1
Sun, X.2
Huang, W.3
Hoage, T.4
Redfield, M.5
-
44
-
-
0030807080
-
Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase
-
Boluyt MO, Zheng JS, Younes A, Long X, O'Neill L, et al. (1997) Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. Circ Res 81: 176-186.
-
(1997)
Circ Res
, vol.81
, pp. 176-186
-
-
Boluyt, M.O.1
Zheng, J.S.2
Younes, A.3
Long, X.4
O'Neill, L.5
-
45
-
-
0028837105
-
Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats
-
Bruckschlegel G, Holmer SR, Jandeleit K, Grimm D, Muders F, et al. (1995) Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Hypertension 25: 250-259.
-
(1995)
Hypertension
, vol.25
, pp. 250-259
-
-
Bruckschlegel, G.1
Holmer, S.R.2
Jandeleit, K.3
Grimm, D.4
Muders, F.5
-
46
-
-
0030924923
-
Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats
-
Regan CP, Anderson PG, Bishop SP, Berecek KH (1997) Pressure-independent effects of AT1-receptor antagonism on cardiovascular remodeling in aortic-banded rats. Am J Physiol 272: H2131-H2138.
-
(1997)
Am J Physiol
, vol.272
-
-
Regan, C.P.1
Anderson, P.G.2
Bishop, S.P.3
Berecek, K.H.4
-
47
-
-
0028042562
-
ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice
-
Rockman HA, Wachhorst SP, Mao L, Ross J (1994) ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 266: H2468-H2475.
-
(1994)
Am J Physiol
, vol.266
-
-
Rockman, H.A.1
Wachhorst, S.P.2
Mao, L.3
Ross, J.4
-
48
-
-
0033083271
-
Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats
-
doi:10.1006/jmcc.1998.0879
-
Baba HA, Iwai T, Bauer M, Irlbeck M, Schmid KW, et al. (1999) Differential effects of angiotensin II receptor blockade on pressure-induced left ventricular hypertrophy and fibrosis in rats. J Mol Cell Cardiol 31: 445-455. doi:10.1006/jmcc.1998.0879.
-
(1999)
J Mol Cell Cardiol
, vol.31
, pp. 445-455
-
-
Baba, H.A.1
Iwai, T.2
Bauer, M.3
Irlbeck, M.4
Schmid, K.W.5
-
49
-
-
0035654317
-
Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy
-
Kiatchoosakun S, Lawrence E, Nakada S, Restivo J, Walsh RA, et al. (2001) Effect of angiotensin type I-receptor blockade on left ventricular remodeling in pressure overload hypertrophy. J Card Fail 7: 342-347.
-
(2001)
J Card Fail
, vol.7
, pp. 342-347
-
-
Kiatchoosakun, S.1
Lawrence, E.2
Nakada, S.3
Restivo, J.4
Walsh, R.A.5
-
50
-
-
0027976362
-
Role of angiotensin in pressure overload-induced hypertrophy in rats: Effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal
-
Mohabir R, Young SD, Strosberg AM (1994) Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal. J Cardiovasc Pharmacol 23: 291-299.
-
(1994)
J Cardiovasc Pharmacol
, vol.23
, pp. 291-299
-
-
Mohabir, R.1
Young, S.D.2
Strosberg, A.M.3
-
51
-
-
0031757520
-
Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan
-
Turcani M, Rupp H (1998) Development of pressure overload induced cardiac hypertrophy is unaffected by long-term treatment with losartan. Mol Cell Biochem 188: 225-233.
-
(1998)
Mol Cell Biochem
, vol.188
, pp. 225-233
-
-
Turcani, M.1
Rupp, H.2
-
52
-
-
33746767569
-
Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors
-
Hamawaki M, Coffman TM, Lashus A, Koide M, Zile MR, et al. (1998) Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am J Physiol 274: H868-H873.
-
(1998)
Am J Physiol
, vol.274
-
-
Hamawaki, M.1
Coffman, T.M.2
Lashus, A.3
Koide, M.4
Zile, M.R.5
-
53
-
-
33846829655
-
Diastolic dysfunction in heart failure with preserved systolic function: Need for objective evidence: Results from the CHARM Echocardiographic Substudy-CHARMES
-
doi:10.1016/j.jacc.2006.08.062
-
Persson H, Lonn E, Edner M, Baruch L, Lang CC, et al. (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 49: 687-694. doi:10.1016/j.jacc.2006.08.062.
-
(2007)
J Am Coll Cardiol
, vol.49
, pp. 687-694
-
-
Persson, H.1
Lonn, E.2
Edner, M.3
Baruch, L.4
Lang, C.C.5
-
54
-
-
20344401818
-
Mechanisms and models in heart failure: The biomechanical model and beyond
-
doi:10.1161/CIRCULATIONAHA.104.500546
-
Mann DL, Bristow MR (2005) Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation 111: 2837-2849. doi:10.1161/ CIRCULATIONAHA.104.500546.
-
(2005)
Circulation
, vol.111
, pp. 2837-2849
-
-
Mann, D.L.1
Bristow, M.R.2
-
55
-
-
84859529833
-
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats
-
doi:10.2337/db11-1468
-
Hashikawa-Hobara N, Hashikawa N, Inoue Y, Sanda H, Zamami Y, et al. (2012) Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats. Diabetes 61: 925-932. doi:10.2337/db11-1468.
-
(2012)
Diabetes
, vol.61
, pp. 925-932
-
-
Hashikawa-Hobara, N.1
Hashikawa, N.2
Inoue, Y.3
Sanda, H.4
Zamami, Y.5
-
56
-
-
79955748837
-
Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome
-
doi:10.1152/ajpheart.00282.2010
-
Jadhav R, Dodd T, Smith E, Bailey E, Delucia AL, et al. (2011) Angiotensin type I receptor blockade in conjunction with enhanced Akt activation restores coronary collateral growth in the metabolic syndrome. Am J Physiol Heart Circ Physiol 300: H1938-H1949. doi:10.1152/ajpheart.00282.2010.
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.300
-
-
Jadhav, R.1
Dodd, T.2
Smith, E.3
Bailey, E.4
Delucia, A.L.5
|